WPI 526 (Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg)
Generic Name: ethinyl estradiol/norgestimate
Pill imprint WPI 526 has been identified as Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg.
Mononessa is used in the treatment of birth control; abnormal uterine bleeding; ovarian cysts; endometriosis; gonadotropin inhibition and belongs to the drug class contraceptives. Not for use in pregnancy. Mononessa ethinyl estradiol 0.035 mg / norgestimate 0.25 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WPI 526
- Generic Name:
- ethinyl estradiol/norgestimate
- ethinyl estradiol 0.035 mg / norgestimate 0.25 mg
- Prescription only
- Drug Class:
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- FD&C Blue No. 2
ferric oxide red
More about Mononessa (ethinyl estradiol / norgestimate)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.